PARP1 and lung cancer: Moreover, LRP1B and DNA damage repair genes (PARP1/2, ERCC1-4, MSH2-6, ATM, BRCA1/2, etc.)mutations have been shown to be associated with favorable outcomes to ICIs in lung cancer (23, 24).